Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 4
2004 5
2005 5
2006 4
2007 2
2008 7
2009 6
2010 6
2011 5
2012 6
2013 8
2014 4
2015 5
2016 7
2017 3
2018 7
2019 7
2020 7
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Impact of antiretroviral therapy intensification with C-C motif chemokine receptor 5 antagonist maraviroc on HIV-associated neurocognitive impairment.
Shikuma CM, Wojna V, De Gruttola V, Siriwardhana C, Souza SA, Rodriguez-Benitez RJ, Turner EH, Kallianpur K, Bolzenius J, Chow D, Matos M, Shiramizu B, Clements DM, Premeaux TA, Ndhlovu LC, Paul R. Shikuma CM, et al. Among authors: shiramizu b. AIDS. 2023 Nov 1;37(13):1987-1995. doi: 10.1097/QAD.0000000000003650. Epub 2023 Jul 6. AIDS. 2023. PMID: 37418541 Free PMC article. Clinical Trial.
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells.
Takata H, Kakazu JC, Mitchell JL, Kroon E, Colby DJ, Sacdalan C, Bai H, Ehrenberg PK, Geretz A, Buranapraditkun S, Pinyakorn S, Intasan J, Tipsuk S, Suttichom D, Prueksakaew P, Chalermchai T, Chomchey N, Phanuphak N, de Souza M, Michael NL, Robb ML, Haddad EK, Crowell TA, Vasan S, Valcour VG, Douek DC, Thomas R, Rolland M, Chomont N, Ananworanich J, Trautmann L; RV254/SEARCH010, RV304/ SEARCH013, and SEARCH011 study groups. Takata H, et al. EBioMedicine. 2022 Oct;84:104253. doi: 10.1016/j.ebiom.2022.104253. Epub 2022 Sep 8. EBioMedicine. 2022. PMID: 36088683 Free PMC article.
A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma.
Goldman S, Barth M, Shiramizu B, Shi Q, Hochberg J, Klejmont L, Harrison L, Basso J, Chu Y, Islam H, Gerard P, Agsalda-Garcia M, Shieh T, Oesterheld J, Heym K, Kirov I, Drachtman R, Harker-Murray P, Perkins S, Miles RR, Cairo M. Goldman S, et al. Among authors: shiramizu b. Leukemia. 2021 Oct;35(10):2994-2997. doi: 10.1038/s41375-021-01256-8. Epub 2021 May 3. Leukemia. 2021. PMID: 33941850 No abstract available.
IDeA States Pediatric Clinical Trials Network for Underserved and Rural Communities.
Annett RD, Chervinskiy S, Chun TH, Cowan K, Foster K, Goodrich N, Hirschfeld M, Hsia DS, Jarvis JD, Kulbeth K, Madden C, Nesmith C, Raissy H, Ross J, Saul JP, Shiramizu B, Smith P, Sullivan JE, Tucker L, Atz AM. Annett RD, et al. Among authors: shiramizu b. Pediatrics. 2020 Oct;146(4):e20200290. doi: 10.1542/peds.2020-0290. Epub 2020 Sep 17. Pediatrics. 2020. PMID: 32943534 Free PMC article.
Hawai'i IDeA Center for Pediatric and Adolescent Clinical Trials.
Shiramizu B, Okihiro MM, Kosut JS, Wu BH, Akshatha A, Neal C Jr, Amiotte A, Siu A, Lee MJ, Balaraman V, Easa D. Shiramizu B, et al. Hawaii J Health Soc Welf. 2020 May 1;79(5 Suppl 1):3-6. Hawaii J Health Soc Welf. 2020. PMID: 32490378 Free PMC article.
Pre-exposure Prophylaxis Therapy and the Blood-Brain Barrier: Is PrEP Neuroprotective?
Kettlewell J, Barney M, Oda R, Agsalda-Garcia M, Siriwardhana C, Shiramizu B. Kettlewell J, et al. Among authors: shiramizu b. J Neuroimmune Pharmacol. 2020 Mar;15(1):10-12. doi: 10.1007/s11481-019-09898-3. Epub 2019 Dec 11. J Neuroimmune Pharmacol. 2020. PMID: 31828733 Free PMC article. No abstract available.
97 results